ATS 2022 Conference News Preview - 20

20 | ATS 2022 CONFERENCE NEWS
ATS Respiratory Innovation Summit:
Accelerating Respiratory Discovery
AFTER A SHORT HIATUS, THE ATS
Respiratory Innovation Summit is back, bringing
together the innovators, investors, clinicians,
and advocacy groups who are leading the charge
to create powerful new
treatments for deadly and
crippling diseases of the
lungs and airways.
Held in conjunction with
the ATS 2022 International
Conference in San Francisco,
the Respiratory Innovation
Summit serves as a platform
for collaboration across industry, academia,
and governmental stakeholders and focuses on
accelerating innovation in three focused areas-
fibrosis, inflammation, and COVID-19.
The ATS 2022 Respiratory Innovation Summit
Timothy Watkins, MD, MSC, vice president of clinical
ATS 2022 RESPIRATORY
INNOVATION SUMMIT
6-7:45 p.m. PT | Friday, May 13
development at Gilead Sciences, long-time ATS member
and past chair of the ATS Committee on Drug Device
Discovery and Development, serves as co-chair of
the 2022 Respiratory Innovation
Summit alongside Cecilia Gonzalo,
MBA, partner at Oberland Capital.
The Friday program begins
7:30 a.m.-5 p.m. PT | Saturday, May 14
San Francisco Marriott Marquis
Separate registration required.
with a networking reception
featuring members of the ATS
Public Advisory Roundtable,
followed by dinner and a
keynote address to be delivered
will be held at the San Francisco Marriott Marquis
Hotel and requires a separate registration from the
International Conference.
" The Respiratory Innovation Summit is an
opportunity for global leaders and innovators from
all areas of the respiratory industry to come together
to share ideas and propose solutions for some of
the most intractable problems in pulmonary, critical
care, and sleep medicine, " said ATS President Lynn M.
Schnapp, MD, ATSF. " It's an opportunity for innovators
to connect with venture capitalists, business
development, patient groups, and thought leaders
who all share a common goal, and that is to advance
respiratory discovery. "
by Freda Lewis-Hall, MD, a pioneer in medicine and
leadership and a passionate advocate for health
equity and improved outcomes for all patients. She
has served in various leadership roles at a number
of pharmaceutical companies, most recently as chief
medical officer and executive vice president, and
later chief patient officer, at Pfizer.
Saturday's program includes a full day of content,
showcasing 15 innovative companies, more than 50
posters from companies looking for investment,
panel discussions, and networking opportunities,
as well as a special Regulatory Keynote address by
Robert J. Meyer, MD, principal for drug and biological
products at Greenleaf Health and associate
professor of public health sciences at the University
of Virginia. Dr. Meyer previously served for 13 years at
the U.S. Food and Drug Administration, including as
director of the Pulmonary Division and as director of
the Office of Drug Evaluation II.
4DMedical
FEATURED SUCCESS STORY
I
n 2019 at the Respiratory
Innovation Summit, Andreas
Fouras, PhD, CEO, and founder
of 4DMedical, shared the
company's vision for functional
lung imaging with an executive
audience from the ATS, investment
groups, government,
and global medical device and
pharmaceutical companies.
The company's novel functional
lung imaging technology
non-invasively tracks the motion
of the lungs, determines
airway volumes, and measures
regional lung ventilation
during spontaneous breathing,
which makes assessment of
lung health uniform and simple
for all patients. Since then,
4DMedical has achieved FDA
approval and a successful IPO.
" As an innovator, I discovered
how incredibly challenging it is
to translate an idea from fundamental
mathematical models
into a functional software
technology platform and take
it beyond a project to become
a business, " Dr. Fouras said.
" Access for everyone is at the
heart of my passion for taking
this technology forward, and
it's at the core of 4DMedical
and everything that we do. "
The ATS gratefully acknowledges the following companies for their
financial support of the ATS 2022 Respiratory Innovation Summit:
INNOVATOR SPONSORS
FEATURED SUCCESS SPONSOR
NETWORKING SPONSORS
https://conference.thoracic.org/program/ris/ https://conference.thoracic.org/program/ris/ https://conference.thoracic.org/ https://conference.thoracic.org/ https://conference.thoracic.org/program/ris/registration.php
ATS 2022 Conference News Preview

Table of Contents for the Digital Edition of ATS 2022 Conference News Preview
